OLA Blog

WKD: Propaganda or Facts?!

Written by Meguid El Nahas on Wednesday, 08 March 2017. Posted in OLA Blog

WKD: Propaganda or Facts?!
The 2017 WKD theme is OBESITY & CKD implying a link between the incidence, progression and outcomes of CKD and Obesity. Presumably a harmful link...?! Whilst I am aware of links between Obesity and the Metabolic syndrome, and between the...

WKD: Propaganda or Facts?!

Written by Meguid El Nahas on Wednesday, 08 March 2017. Posted in OLA Blog

WKD: Propaganda or Facts?!
The 2017 WKD theme is Obesity and CKD implying a link between the incidence, progression and outcomes of CKD and Obesity. Whilst I am aware of links between Obesity and the Metabolic syndrome, and between the metabolic Syndrome and...

OLA Tweet: Salt Restriction in CKD

Written by Meguid El Nahas on Sunday, 19 February 2017. Posted in OLA Blog

OLA Tweet: Salt Restriction in CKD
Prof Pierre Delanaye TWEETED:    A cheap and (relatively) simple intervention to improve HTA in CKD! Don't forget it! This is a RCT!     Clin J Am Soc Nephrol. 2017 Feb 16. pii: CJN.01120216. doi:...

AVF: Fish Oil, Aspirin or Nothing...?

Written by Meguid El Nahas on Saturday, 14 January 2017. Posted in OLA Blog

AVF: Fish Oil, Aspirin or Nothing...?
Prof Pierre Delanaye posted: FISH OIL or ASPIRIN for AVF maturation: does not wok!Written by Pierre Delanaye on Monday, 09 January 2017. Posted in OLA BlogJAMA Intern Med. 2017 Jan 3. doi: 10.1001/jamainternmed.2016.8029. [Epub ahead of...

ELEVATE: Rather not....

Written by Meguid El Nahas on Wednesday, 04 January 2017. Posted in OLA Blog

ELEVATE: Rather not....
Am J Transplant. 2016 Dec 27. doi: 10.1111/ajt.14186. [Epub ahead of print] Early conversion from calcineurin inhibitor- to everolimus-based therapy following kidney transplantation: Results of the randomized ELEVATE trial....

ASN 2016: Onco-Nephrology

Written by Meguid El Nahas on Wednesday, 23 November 2016. Posted in OLA Blog

ASN 2016: Onco-Nephrology
Prof Richard Glassock wrote: I went to a session on Onco-Nephrology at the ASN meeting yesterday.  Two randomized controlled trials of high-cut off (HCO) membrane intermittent hemodialysis compared to standard membrane hemodialysis for...

ASN 2016: Late Breaking Clinical Trials

Written by Meguid El Nahas on Sunday, 20 November 2016. Posted in OLA Blog

ASN 2016: Late Breaking Clinical Trials
Prof Arif Khwaja Reporting from Chicago: Late Breaking Clinical Trials LEADER study looking at Liraglutatide on renal outcomes in patients with T2DM. This was a huge study with over 8000 patients with T2DM at higher CV risk who were randomised...

PPIs & CKD: "Do No Harm"...?!

Written by Meguid El Nahas on Monday, 17 October 2016. Posted in OLA Blog

PPIs & CKD: "Do No Harm"...?!
BLOG BY PROFESSOR PIERRE DELANAYE: PPI and CKD: an association… but is it causality? Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193....

A RCT trial in hemodialysis patients: fistula

Written by Pierre Delanaye on Monday, 10 October 2016. Posted in OLA Blog

A RCT trial in hemodialysis patients: fistula
Lancet. 2016 Sep 10;388(10049):1067-74. doi: 10.1016/S0140-6736(16)30948-5. Epub 2016 Aug 1. Effect of regional versus local anaesthesia on outcome after arteriovenous fistula creation: a randomised controlled trial. Aitken...

Radiocontrast Nephrotoxicity: A Myth?!

Written by Meguid El Nahas on Friday, 07 October 2016. Posted in OLA Blog

Radiocontrast Nephrotoxicity: A Myth?!
J Am Soc Nephrol. 2016 Sep 29. pii: ASN.2016010021. [Epub ahead of print] Estimating the Risk of Radiocontrast-Associated Nephropathy. Wilhelm-Leen E, Montez-Rath ME, Chertow G Abstract Estimates of the incidence...